Bristol-Myers Squibb CompanyFive Year Competitive Advance and Revolving Credit Facility Agreement • July 23rd, 2015 • Bristol Myers Squibb Co • Pharmaceutical preparations
Reference is made to the Five Year Competitive Advance and Revolving Credit Facility Agreement, dated as of September 29, 2011, as amended, supplemented or otherwise modified prior to the date hereof (the “Credit Agreement”) among Bristol-Myers Squibb Company, a Delaware corporation (the “Company”), the Borrowing Subsidiaries, the lenders parties thereto (the “Lenders”), certain Agents, Citibank, N.A., as Administrative Agent, and JPMorgan Chase Bank, N.A., as Administrative Agent. Capitalized terms used but not defined herein shall have the meaning assigned to such terms in the Credit Agreement.
Bristol-Myers Squibb CompanyFive Year Competitive Advance and Revolving Credit Facility Agreement • July 23rd, 2015 • Bristol Myers Squibb Co • Pharmaceutical preparations
Reference is made to the Five Year Competitive Advance and Revolving Credit Facility Agreement (the “Credit Agreement”) dated as of July 30, 2012 among Bristol-Myers Squibb Company, a Delaware corporation (the “Company”), the Borrowing Subsidiaries, the lenders parties thereto (the “Lenders”), certain Agents, Citibank, N.A., as Administrative Agent, and JPMorgan Chase Bank, N.A., as Administrative Agent. Capitalized terms used but not defined herein shall have the meaning assigned to such terms in the Credit Agreement.
